Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02441712 · ClinicalTrials.gov registry record · NA

Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT02441712 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02441712, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This is a Randomized Controlled Trial (RCT) regarding the conservative treatment of patellofemoral pain (PFP) with an impairment based rehabilitation program. Those with PFP can have a variety of impairments, such as knee and hip muscle weakness, poor movement patterns, weak core activation and muscle tightness. Several recent RCT trials have looked at treating single impairments, but to date no RCT have address individualized patient impairments during a rehabilitation program. Abnormal muscle firing patterns have also been identified during functional tasks; such as jogging, stair climbing, and performing a single leg squat. Conflicting studies have produced changes to the quadriceps and hip muscle firing patterns with those with PFP. The abnormal activation patterns has been suggested to be why strengthening programs alone do not improve movement patterns during functional tasks for those with PFP. Patterned electrical neuromuscular stimulation (PENS) is a novel form of electrical stimulation that replicates proper firing patterns based off healthy electromyography patterns. The purpose of the study is to investigate the benefits of PENS with a impairment based rehabilitation program for the treatment of PFP. The rationale for this investigation is to assess the benefits of PENS with therapeutic exercise at improving altered firing patterns of the lower extremity muscles during functional tasks.

Interventions

  • DEVICE PENS

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2015-03
Est. Completion 2017-12
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT02441712

The ClinicalTrials.gov registry entry for NCT02441712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PENS is the first listed.

NCT02441712 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02441712 about?

NCT02441712 is a clinical study titled "Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain". This is a Randomized Controlled Trial (RCT) regarding the conservative treatment of patellofemoral pain (PFP) with an impairment based rehabilitation program. Those with PFP can have a variety of impairments, such as knee and hip muscle weakness, poor movement patterns, weak core activation and musc...

What is the current status of trial NCT02441712?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2015-03. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02441712?

The interventions under investigation include: PENS (DEVICE).

Who is sponsoring clinical trial NCT02441712?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.